MedTrace Logo

Prospective Longitudinal Monocentric Study to Evaluate the Syde® Digital Endpoint in Patients With Multiple Sclerosis

NCT06346704 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2025-12-15

No results posted yet for this study

Summary

The study aims to assess the validity of real-world activity monitoring by the Syde® wearable device in subjects with multiple slclerosis. The Syde® collected data will be compared to on-site conventional clinical endpoints for MS pathology (EDSS, FSS and T25FWT). Subjects with multiple sclerosis will be assessed every 6 months for 2 years.

Conditions

Interventions

OTHER

Digital HealthTechnology

Subject will wear the Syde® for 1 month every 6 months

Sponsors & Collaborators

  • SYSNAV

    lead INDUSTRY

Principal Investigators

  • Ahmed Elnemr, MD · Air Force Specialized Hospital Cairo

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-25
Primary Completion
2025-04-25
Completion
2025-04-25

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06346704 on ClinicalTrials.gov